Functional epigenetic approach identifies frequently methylated genes in Ewing sarcoma

Epigenetics

Volumn 8, Issue 11, 2013, Pages 1198-1204

  Alholle, Abdullah ^a   Brini, Anna T ^b,c   Gharanei, Seley ^a   Vaiyapuri, Sumathi ^a   Arrigoni, Elena ^b   Dallol, Ashraf ^d   Gentle, Dean ^a   Kishida, Takeshi ^e   Hiruma, Toru ^e   Avigad, Smadar ^f   Grimer, Robert ^a   Maher, Eamonn R ^a   Latif, Farida ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^d KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^e KANAGAWA CANCER CENTER   (Japan)

^f TEL AVIV UNIVERSITY   (Israel)

Author keywords

5 aza 2 deoxycytidine; Bone tumors; Ewing sarcoma; Functional epigenomics; Osteosarcoma

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CTHRC1 GENE; DNA METHYLATION; DNAJA4 GENE; ECHDC2 GENE; EPIGENETICS; EWING SARCOMA; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; NEFH GENE; NPTX2 GENE; OSTEOSARCOMA; PHF11 GENE; RASSF2 GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL; TSGA14 GENE;

5-AZA-2'-DEOXYCYTIDINE; BONE TUMORS; EWING SARCOMA; FUNCTIONAL EPIGENOMICS; OSTEOSARCOMA;

BONE NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; GENE SILENCING; HUMANS; MESENCHYMAL STROMAL CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SARCOMA, EWING; SURVIVAL RATE; TRANSCRIPTOME;

EID: 84887444200     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.26266     Document Type: Article

References (24)

1. Toomey EC, Schiffman JD, Lessnick SL. Recent advances in the molecular pathogenesis of Ewing's sarcoma. Oncogene 2010; 29:4504-4516; PMID:20543858; http://dx.doi.org/10.1038/ onc.2010.205
2. Shukla N, Schiffman J, Reed D, Davis IJ, Womer RB, Lessnick SL, Lawlor ER; COG Ewing Sarcoma Biology Committee. Biomarkers in Ewing Sarcoma: The Promise and Challenge of Personalized Medicine. A Report from the Children's Oncology Group. Front Oncol 2013; 3:141; PMID:23761859
3. Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat Rev Genet 2012; 13:679-692; PMID:22945394; http:// dx.doi.org/10.1038/nrg3270
4. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343:1350-1354; PM I D: 110 70 0 9 8; http://dx.doi.org/10.1056/NEJM200011093431901
5. Brock MV, Hooker CM, Ota-Machida E, Han Y, Guo M, Ames S, Glöckner S, Piantadosi S, Gabrielson E, Pridham G, et al. DNA methylation markers and early recurrence in stage I lung cancer. N Engl J Med 2008; 358:1118-1128; PMID:18337602; http://dx.doi. org/10.1056/NEJMoa0706550
6. Chen WD, Han ZJ, Skoletsky J, Olson J, Sah J, Myeroff L, Platzer P, Lu S, Dawson D, Willis J, et al. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 2005; 97:1124-1132; PMID:16077070; http://dx.doi.org/10.1093/jnci/dji204
7. Itzkowitz S, Brand R, Jandorf L, Durkee K, Millholland J, Rabeneck L, Schroy PC, Sontag S, Johnson D, Markowitz S, et al. A simplified, noninvasive stool DNA test for colorec-tal cancer detection. Am J Gastroenterol 2008; 103:2862-2870; PMID:18759824; http://dx.doi. org/10.1111/j.1572-0241.2008.02088.x
8. Gharanei S, Brini AT, Vaiyapuri S, Alholle A, Dallol A, Arrigoni E, Kishida T, Hiruma T, Avigad S, Grimer R, et al. RASSF2 methylation is a strong prognostic marker in younger age patients with Ewing sarcoma. Epigenetics 2013; 8: In press; PMID:23887284; http: //d x.doi. org /10. 4161/ epi. 25 617.
9. Morris MR, Gentle D, Abdulrahman M, Maina EN, Gupta K, Banks RE, Wiesener MS, Kishida T, Yao M, Teh B, et al. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma. Cancer Res 2005; 65:4598-4606; PM ID:1593 0277; http://dx.doi.org/10.1158/0008-5472.CAN-04-3371
10. Morris MR, Ricketts C, Gentle D, Abdulrahman M, Clarke N, Brown M, Kishida T, Yao M, Latif F, Maher ER. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010; 29:2104-2117; PMID:20154727; http://dx.doi.org/10.1038/onc.2009.493
11. Wang P, Wang YC, Chen XY, Shen ZY, Cao H, Zhang YJ, Yu J, Zhu JD, Lu YY, Fang JY. CTHRC1 is upregulated by promoter demethylation and transforming growth factor-β1 and may be associated with metastasis in human gastric cancer. Cancer Sci 2012; 103:1327-1333; PMID:22590977; http://dx.doi. org /10.1111/j.13 49-7006.2012.02292.x
12. Mahoney SE, Yao Z, Keyes CC, Tapscott SJ, Diede SJ. Genome-wide DNA methylation studies suggest distinct DNA methylation patterns in pediat-ric embryonal and alveolar rhabdomyosarcomas. Epigenetics 2012; 7:400-408; PMID:22419069; http:// dx.doi.org/10.4161/epi.19463
13. Licchesi JD, Van Neste L, Tiwari VK, Cope L, Lin X, Baylin SB, Herman JG. Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-Myc. Oncogene 2010; 29:5923-5934; PMID:20697356; http://dx.doi. org/10.1038/onc.2010.322
14. Ohali A, Avigad S, Cohen IJ, Meller I, Kollender Y, Issakov J, Goshen Y, Yaniv I, Zaizov R. High frequency of genomic instability in Ewing family of tumors. Cancer Genet Cytogenet 2004; 150:50-56; PMID:15041223; http://dx.doi.org/10.1016/j. cancergencyto.2003.08.014
15. Kim MS, Chang X, LeBron C, Nagpal JK, Lee J, Huang Y, Yamashita K, Trink B, Ratovitski EA, Sidransky D. Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma. PLoS One 2010; 5:e9003; PMID:20140245; http://dx.doi. org/10.1371/journal.pone.0009003
16. Sato N, Fukushima N, Maitra A, Matsubaya Shi H, Yeo CJ, Cameron JL, Hruban RH, Goggins M. Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays. Cancer Res 2003; 63:3735-3742; PMID:12839967
17. Park JK, Ryu JK, Yoon WJ, Lee SH, Lee GY, Jeong KS, Kim YT, Yoon YB. The role of quantitative NPTX2 hypermethylation as a novel serum diagnostic marker in pancreatic cancer. Pancreas 2012; 41:95-101; PMID:21778928; http://dx.doi.org/10.1097/MPA.0b013e318221c903
18. Zhang L, Gao J, Li L, Li Z, Du Y, Gong Y. The neuro-nal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro. Mol Biol Rep 2011; 38:4903-4911; PMID:21161403; http://dx.doi.org/10.1007/s11033-010-0632-y
19. Ko JM, Chan PL, Yau WL, Chan HK, Chan KC, Yu ZY, Kwong FM, Miller LD, Liu ET, Yang LC, et al. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esopha-geal carcinoma. Mol Cancer Res 2008; 6:592-603; PMID:18403638; h t t p://dx. doi. o rg/10.115 8 /15 41-7786.MCR-07-0154
20. Rechache NS, Wang Y, Stevenson HS, Killian JK, Edelman DC, Merino M, Zhang L, Nilubol N, Stratakis CA, Meltzer PS, et al. DNA methylation profiling identifies global methylation differences and markers of adrenocortical tumors. J Clin Endocrinol Metab 2012; 97:E1004-1013; PMID:22472567; http:// dx.doi.org/10.1210/jc.2011-3298
21. Fernandez-Ranvier GG, Weng J, Yeh RF, Khanafshar E, Suh I, Barker C, Duh QY, Clark OH, Kebebew E. Identification of biomarkers of adrenocorti-cal carcinoma using genomewide gene expression profiling. Arch Surg 2008; 143:841-846, discussion 846; PMID:18794420; http://dx.doi.org/10.1001/ archsurg.143.9.841
22. Yamada T, Kayashima T, Yamasaki K, Ohta T, Yoshiura Ki, Matsumoto N, Fujimoto S, Niikawa N, Kishino T. The gene TSGA14, adjacent to the imprinted gene MEST, escapes genomic imprinting. Gene 2002; 288:57-63; PMID:12034494; http:// dx.doi.org/10.1016/S0378-1119(02)00428-6
23. Avigad S, Shukla S, Naumov I, Cohen IJ, Ash S, Meller I, Kollender Y, Issakov J, Yaniv I. Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma. Pediatr Blood Cancer 2009; 53:1023-1028; PM I D:19 63 7319; http://dx.doi. org/10.1002/pbc.22115
24. Ricketts CJ, Morris MR, Gentle D, Brown M, Wake N, Woodward ER, Clarke N, Latif F, Maher ER. Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma. Epigenetics 2012; 7:278-290; PMID:22430804; http://dx.doi.org/10.4161/epi.7.3.19103